Interaction Checker

Interaksi Ambrisentan

Ambrisentan (Letairis) memiliki 34 interaksi terdokumentasi dalam label FDA dan lembar fakta yang kami indeks: 0 mayor, 2 moderat, 32 minor, dan 0 dengan label yang melaporkan tidak ada interaksi bermakna. Setiap entri di bawah ini mengutip kalimat yang mendasarinya. Halaman obat ini adalah titik awal, bukan putusan untuk situasi Anda.

Seperti apa tampilan Ambrisentan

Semua 18 versi
Tablet Ambrisentan 10 mg: merah, oval, 10 mm, dengan kode cetak GSI di satu sisi dan 10 di sisi lainnya.
GSI / 10
10 mg · merah · oval · 10 mm
Gilead Sciences
Tablet Ambrisentan 5 mg: merah muda, persegi, 7 mm, dengan kode cetak GSI di satu sisi dan 5 di sisi lainnya.
GSI / 5
5 mg · merah muda · persegi · 7 mm
Gilead Sciences
Tablet Ambrisentan 5 mg: merah muda, bulat, 8 mm, dengan kode cetak 1179.
1179
5 mg · merah muda · bulat · 8 mm
Zydus Pharmaceuticals
Tablet Ambrisentan 10 mg: putih, oval, 10 mm, dengan kode cetak 1180.
1180
10 mg · putih · oval · 10 mm
Zydus Pharmaceuticals

Gambar hasil render dari daftar produk pada label FDA: warna, bentuk, ukuran, dan kode cetak. 18 versi terdokumentasi dari 11 pelabel.

Interaksi dari label

Interaksi moderat (2)

  • LomitapidModerat

    Coadministration of lomitapide with P-gp substrates (such as aliskiren, ambrisentan, colchicine, dabigatran etexilate, digoxin, everolimus, fexofenadine, imatinib, lapatinib, maraviroc, nilotinib, posaconazole, ranolazine, saxagliptin, sirolimus, sitagliptin, talinolol, tolvaptan, topotecan) may increase the absorption of P-gp substrates. (label Lomitapid, Interaksi obat)

  • SiklosporinimunosupresanModerat

    Multiple dose coadministration of ambrisentan and cyclosporine resulted in an approximately 2-fold increase in ambrisentan exposure in healthy volunteers; therefore, limit the dose of ambrisentan to 5 mg once daily when coadministered with cyclosporine [see Clinical Pharmacology (12.3) ] . (label Ambrisentan, Interaksi obat)

Penyebutan minor (32)

  • Amiloriddiuretik hemat kaliumMinor

    Patients required intervention with a diuretic, fluid management, or, in some cases, hospitalization for decompensating heart failure. (label Ambrisentan, Peringatan dan perhatian)

  • Asam etakrinatdiuretik loopMinor

    Patients required intervention with a diuretic, fluid management, or, in some cases, hospitalization for decompensating heart failure. (label Ambrisentan, Peringatan dan perhatian)

  • Asetazolamidpenghambat karbonat anhidraseMinor

    Patients required intervention with a diuretic, fluid management, or, in some cases, hospitalization for decompensating heart failure. (label Ambrisentan, Peringatan dan perhatian)

  • Atenolol dan klortalidonpenyekat betaMinor

    Patients required intervention with a diuretic, fluid management, or, in some cases, hospitalization for decompensating heart failure. (label Ambrisentan, Peringatan dan perhatian)

  • Benazepril dan hidroklorotiazidpenghambat ACEMinor

    Patients required intervention with a diuretic, fluid management, or, in some cases, hospitalization for decompensating heart failure. (label Ambrisentan, Peringatan dan perhatian)

  • Bisoprolol dan hidroklorotiazidpenyekat betaMinor

    Patients required intervention with a diuretic, fluid management, or, in some cases, hospitalization for decompensating heart failure. (label Ambrisentan, Peringatan dan perhatian)

  • Bumetaniddiuretik loopMinor

    Patients required intervention with a diuretic, fluid management, or, in some cases, hospitalization for decompensating heart failure. (label Ambrisentan, Peringatan dan perhatian)

  • Enalapril dan hidroklorotiazidpenghambat ACEMinor

    Patients required intervention with a diuretic, fluid management, or, in some cases, hospitalization for decompensating heart failure. (label Ambrisentan, Peringatan dan perhatian)

  • Eplerenonantagonis aldosteronMinor

    Patients required intervention with a diuretic, fluid management, or, in some cases, hospitalization for decompensating heart failure. (label Ambrisentan, Peringatan dan perhatian)

  • Fosinopril dan hidroklorotiazidpenghambat ACEMinor

    Patients required intervention with a diuretic, fluid management, or, in some cases, hospitalization for decompensating heart failure. (label Ambrisentan, Peringatan dan perhatian)

  • Furosemiddiuretik loopMinor

    Patients required intervention with a diuretic, fluid management, or, in some cases, hospitalization for decompensating heart failure. (label Ambrisentan, Peringatan dan perhatian)

  • Hidroklorotiaziddiuretik tiazidMinor

    Patients required intervention with a diuretic, fluid management, or, in some cases, hospitalization for decompensating heart failure. (label Ambrisentan, Peringatan dan perhatian)

  • Indapamiddiuretik tiazidMinor

    Patients required intervention with a diuretic, fluid management, or, in some cases, hospitalization for decompensating heart failure. (label Ambrisentan, Peringatan dan perhatian)

  • Irbesartan dan hidroklorotiazidpenghambat reseptor angiotensin II (ARB)Minor

    Patients required intervention with a diuretic, fluid management, or, in some cases, hospitalization for decompensating heart failure. (label Ambrisentan, Peringatan dan perhatian)

  • Kandesartan dan hidroklorotiazidpenghambat reseptor angiotensin II (ARB)Minor

    Patients required intervention with a diuretic, fluid management, or, in some cases, hospitalization for decompensating heart failure. (label Ambrisentan, Peringatan dan perhatian)

  • Klorotiaziddiuretik tiazidMinor

    Patients required intervention with a diuretic, fluid management, or, in some cases, hospitalization for decompensating heart failure. (label Ambrisentan, Peringatan dan perhatian)

  • Klortalidondiuretik tiazidMinor

    Patients required intervention with a diuretic, fluid management, or, in some cases, hospitalization for decompensating heart failure. (label Ambrisentan, Peringatan dan perhatian)

  • Kuinapril dan hidroklorotiazidpenghambat ACEMinor

    Patients required intervention with a diuretic, fluid management, or, in some cases, hospitalization for decompensating heart failure. (label Ambrisentan, Peringatan dan perhatian)

  • Lisinopril dan hidroklorotiazidpenghambat ACEMinor

    Patients required intervention with a diuretic, fluid management, or, in some cases, hospitalization for decompensating heart failure. (label Ambrisentan, Peringatan dan perhatian)

  • Losartan dan hidroklorotiazidpenghambat reseptor angiotensin II (ARB)Minor

    Patients required intervention with a diuretic, fluid management, or, in some cases, hospitalization for decompensating heart failure. (label Ambrisentan, Peringatan dan perhatian)

  • Metolazondiuretik tiazidMinor

    Patients required intervention with a diuretic, fluid management, or, in some cases, hospitalization for decompensating heart failure. (label Ambrisentan, Peringatan dan perhatian)

  • Metoprolol dan hidroklorotiazidpenyekat betaMinor

    Patients required intervention with a diuretic, fluid management, or, in some cases, hospitalization for decompensating heart failure. (label Ambrisentan, Peringatan dan perhatian)

  • Olmesartan dan hidroklorotiazidpenghambat reseptor angiotensin II (ARB)Minor

    Patients required intervention with a diuretic, fluid management, or, in some cases, hospitalization for decompensating heart failure. (label Ambrisentan, Peringatan dan perhatian)

  • Olmesartan, amlodipin, dan hidroklorotiazidpenghambat reseptor angiotensin II (ARB)Minor

    Patients required intervention with a diuretic, fluid management, or, in some cases, hospitalization for decompensating heart failure. (label Ambrisentan, Peringatan dan perhatian)

  • Spironolaktonantagonis aldosteronMinor

    Patients required intervention with a diuretic, fluid management, or, in some cases, hospitalization for decompensating heart failure. (label Ambrisentan, Peringatan dan perhatian)

  • Spironolakton dan hidroklorotiazidantagonis aldosteronMinor

    Patients required intervention with a diuretic, fluid management, or, in some cases, hospitalization for decompensating heart failure. (label Ambrisentan, Peringatan dan perhatian)

  • Tadalafilpenghambat PDE5Minor

    Peripheral edema/fluid retention is more common with Letairis plus tadalafil than with Letairis or tadalafil alone. (label Ambrisentan, Peringatan dan perhatian)

  • Telmisartan dan hidroklorotiazidpenghambat reseptor angiotensin II (ARB)Minor

    Patients required intervention with a diuretic, fluid management, or, in some cases, hospitalization for decompensating heart failure. (label Ambrisentan, Peringatan dan perhatian)

  • Torasemiddiuretik loopMinor

    Patients required intervention with a diuretic, fluid management, or, in some cases, hospitalization for decompensating heart failure. (label Ambrisentan, Peringatan dan perhatian)

  • Triamterendiuretik hemat kaliumMinor

    Patients required intervention with a diuretic, fluid management, or, in some cases, hospitalization for decompensating heart failure. (label Ambrisentan, Peringatan dan perhatian)

  • Triamteren dan hidroklorotiaziddiuretik hemat kaliumMinor

    Patients required intervention with a diuretic, fluid management, or, in some cases, hospitalization for decompensating heart failure. (label Ambrisentan, Peringatan dan perhatian)

  • Valsartan dan hidroklorotiazidpenghambat reseptor angiotensin II (ARB)Minor

    Patients required intervention with a diuretic, fluid management, or, in some cases, hospitalization for decompensating heart failure. (label Ambrisentan, Peringatan dan perhatian)

Periksa Ambrisentan terhadap semua yang Anda gunakan. Tambahkan seluruh daftar Anda; setiap pasangan diperiksa sekaligus.

Buka di pemeriksa

Bukan nasihat medis. Tingkat keparahan mencerminkan kata-kata dalam label, bukan keadaan Anda. Tanda “mayor” bisa merupakan hal yang rutin di bawah pengawasan, dan tanda “minor” bisa menjadi penting pada dosis tinggi. Tanyakan kepada apoteker.